Avantium
Edit

Avantium

https://www.avantium.com/
Last activity: 12.06.2025
Active
Categories: ChemicalChemicalsDevelopmentEnergyTechIndustryMaterialsProductProductionServiceTechnology
Avantium is a leading chemical technology company and a forerunner in renewable chemistry. Based on extensive experience and advanced catalytic research Avantium develops efficient processes and sustainable products made from biobased materials. Avantium offers a breeding ground for revolutionary renewable chemistry solutions. From invention to commercially viable production processes.

One of Avantium’s success stories is the YXY technology®, with which it created PEF: a completely new, high-quality plastic made from plant-based industrial sugars. Avantium is working on a host of other groundbreaking projects such as a second generation technology process, or biorefinery technology, to produce sugars for the production of chemicals and fuels from non-food materials. The proprietary process is highly feedstock-flexible allowing use of forestry residues (e.g. woodchip), corn-stover, bagasse, sugar beet residue and produces a high purity 2G glucose product and lignin for energy and other applications; all in near quantitative yield.

Avantium’s offices and headquarters are based in Amsterdam, the Netherlands. Over 140 highly skilled colleagues representing 20 nationalities, Avantium fosters a dynamic and enthusiastic workplace that is constantly seeking new ways to improve and expand the impact of advanced catalytic research & technology. We ask of our employees what we ask of our company: collaborative, open-minded and results-driven creativity. In an ever-changing world Avantium is ambitiously chasing exciting new ideas and initiatives.
Likes
483
Followers
2.4K
Website visits
12.5K /mo.
Mentions
45
Location: Netherlands, North Holland, Amsterdam
Employees: 201-500
Phone: +31 20 586 8080
Total raised: $417.03M
Founded date: 2000

Investors 4

Funding Rounds 6

DateSeriesAmountInvestors
12.02.2024-$75.4M-
13.04.2017-$115.71M-
14.03.2017IPO$109.3M-
19.04.2016-$22.71M-
05.06.2014-$50M-
10.06.2011-$43.9M-

Mentions in press and media 45

DateTitleDescription
12.06.2025The growth and opportunities of the Netherlands' tech ecosystemDutch tech companies raised over €3.7 billion in 2024, accounting for about 5 per cent of the total capital raised in the European tech ecosystem, according to Tech.eu's European Tech 2024: The Big Picture report. This positions the Netherl...
14.02.2025A New Era for Industrial Biotechnology in the UKThe landscape of industrial biotechnology is shifting. The appointment of Dr. Peter Williams as the new chair of the Industrial Biotechnology Innovation Centre (IBioIC) marks a pivotal moment. With over 40 years in the chemicals industry, W...
14.02.2025The Rise of Bioeconomy and AI: Navigating New Frontiers in InnovationIn the evolving landscape of technology and sustainability, two significant forces are emerging: the bioeconomy and artificial intelligence (AI). Each is a powerful engine driving innovation, reshaping industries, and creating new opportuni...
14.02.2025The Rise of Bioeconomy and Auto Parts: A Tale of Two IndustriesIn the landscape of modern industry, two narratives emerge. One revolves around the bioeconomy, a sector gaining traction in Scotland. The other focuses on India's burgeoning auto parts industry, where private equity is making waves. Both s...
13.02.2025INEOS Stalwart Named as New IBioIC ChairThe Industrial Biotechnology Innovation Centre (IBioIC) has appointed Dr Peter Williams, group technology director and head of investor relations at INEOS, to lead its governing board and support the centre’s continued impact on the growing...
18.10.2024Funding the future: Europe’s biggest cleantech fundraisers for the first three quarters of 2024Cleantech companies play a crucial role in the European tech ecosystem by driving innovation and sustainability. They contribute to the reduction of carbon emissions and the transition to a circular economy, helping combat climate change. B...
10.09.2024NanoSyrinx: A New Dawn in Biotech with £10 Million FundingIn the world of biotechnology, innovation is the lifeblood. Today, a new player is making waves. NanoSyrinx, a synthetic biology company based in Coventry, UK, has successfully raised approximately £10 million (around $13 million) in a rece...
10.09.2024NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as ChairmanRound co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in ...
10.09.2024NanoSyrinx Closes Approx. £10M FinancingNanoSyrinx, a Coventry, UK-based synthetic biology company, raised approx. £10M in funding. The round was led by BGF, Octopus Ventures and M Ventures, with participation from new corporate investor, Eli Lilly and Company, and existing inves...
26.03.2024Meet the companies that raised the top 8 Dutch funding rounds in Q1 2024; all are hiring right nowRead this article in: The last quarter of 2023 ended as the best quarter of the year for the Netherlands in terms of deals and total amount invested, with Q4 contributing €576M to the €1.5B total. Now, the Netherlands is closing Q1 2024 on ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In